• 2:41

  Ethical considerations of biomarker use in prodromal Alzheimer’s disease

  Giovanni Frisoni

  There are currently no approved preventive or disease-modifying therapies available for Alzheimer’s disease. At the 2nd Congress of the European…
• 1:30

  Introducing Alzheimer Society, a UK dementia support and research charity

  Doug Brown

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Doug Brown,…
• 1:13

  Improving dementia care: Integrating evidence into clinical practice

  Wendy Moyle

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Wendy Moyle,…
• 1:13

  Emerging risk factors for preventing dementia

  Martin Orrell

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Martin Orrell,…
• 1:58

  Improving dementia care through research

  Martin Orrell

  At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Martin Orrell,…